What is CBD?

CBD, or Cannabidiol, is one of the many compounds found in the cannabis plant. Unlike THC (tetrahydrocannabinol), which is the primary psychoactive component in cannabis, CBD doesn't produce the "high" typically associated with cannabis use. In recent years, it has generated significant interest among researchers, medical professionals, and patients due to it's potential therapeutic benefits for various health conditions.

The TGA (Therapeutic Goods Administration) in Australia is responsible for regulating therapeutic goods. In recent times, the TGA has acknowledged the therapeutic potential of medicinal cannabis products, including CBD, for specific conditions. According to TGA guidelines:

• CBD and other medicinal cannabis products can be prescribed for conditions where there's clinical evidence of its efficacy, or as part of a clinical trial.

• The TGA has also provided guidance on conditions and symptoms that can be considered for medicinal cannabis treatment, which include chronic pain, chemotherapy-induced nausea and vomiting, epilepsy, and more.

Conditions for which CBD may be beneficial

Epilepsy

CBD (Cannabidiol) has emerged as a potential therapeutic agent for epilepsy, especially for certain refractory forms of the condition that don't respond well to traditional antiepileptic drugs.

1. Dravet Syndrome and Lennox-Gastaut Syndrome: Two severe forms of epilepsy, Dravet Syndrome and Lennox-Gastaut Syndrome, are particularly challenging to treat. Clinical trials have found that CBD can significantly reduce seizure frequency in these conditions. Based on these findings, Epidiolex, a purified form of CBD, became the first FDA-approved drug derived from cannabis to treat these syndromes.

2. Mechanism of Action: The exact mechanism through which CBD exerts its antiepileptic effects remains incompletely understood. It's believed to involve various pathways, including modulation of calcium and sodium channels, enhancement of the inhibitory neurotransmitter GABA, and anti-inflammatory actions through the endocannabinoid system.

3. CBD as an Add-On Therapy: For patients who don’t fully respond to conventional antiepileptic drugs, CBD can be used as an adjunctive therapy. Some studies have indicated a reduction in seizure frequency when CBD is added to existing treatment regimens.

Mental Health Conditions

Anxiety Disorders: CBD has demonstrated potential anxiolytic (anxiety-reducing) effects in both animal and human studies. Clinical trials have shown that CBD might help reduce symptoms in social anxiety disorder, generalized anxiety disorder, and other anxiety-related conditions. Depression: Preclinical studies in rodents have indicated that CBD can produce antidepressant-like effects, potentially through its impact on serotonin receptors in the brain. Post-Traumatic Stress Disorder (PTSD): CBD might be beneficial in mitigating the symptoms of PTSD. It's postulated that CBD may influence the endocannabinoid system, which plays a role in memory consolidation and retrieval. Schizophrenia and Psychoses: While THC (a major psychoactive component of cannabis) has been associated with exacerbating psychotic symptoms, CBD has shown antipsychotic properties in several studies. Clinical trials have suggested that CBD might be a promising treatment for schizophrenia. Substance Use Disorders: CBD has shown promise in reducing the cravings and withdrawal symptoms associated with various substance use disorders, including opioid, cocaine, and tobacco dependencies.

Pain Related Conditions

Neuropathic Pain: Neuropathic pain results from nerve injury or dysfunction. Studies have indicated that CBD might have potential in alleviating neuropathic pain. A notable mechanism is through CBD's ability to enhance the activity of serotonin receptors, which play a role in pain perception. Inflammatory Pain: Chronic inflammation can result in pain. CBD has demonstrated anti-inflammatory properties, suggesting its potential efficacy in conditions like arthritis. Migraine: Preliminary research suggests that CBD, in combination with THC, might help reduce the frequency and severity of migraines. Chronic Pain: Chronic pain is a multifaceted condition, but studies indicate that CBD might help alleviate pain symptoms in various chronic pain conditions. Cancer-related Pain: Some cancer patients do not obtain sufficient relief from traditional painkillers. CBD has been studied as an adjunct therapy for cancer-related pain, sometimes in combination with THC.

Neurodegenerative Disorders

Preliminary research suggests CBD might have neuroprotective properties, which could be beneficial for conditions like Alzheimer's and Parkinson's disease.

1. Alzheimer's Disease (AD): Inflammation plays a role in the progression of AD. CBD has demonstrated anti-inflammatory properties that may help counteract neuroinflammatory responses. CBD may also reduce the neurotoxic effects of beta-amyloid peptide, implicated in the pathogenesis of AD.

2. Parkinson's Disease (PD): PD is characterized by the death of dopaminergic neurons. Preclinical studies have indicated that CBD may offer protection to these neurons. CBD may also have potential in reducing the levodopa-induced dyskinesia in PD patients.

3. Huntington's Disease: Although research is limited, initial studies suggest that CBD might have neuroprotective properties that could benefit individuals with Huntington's disease.

4. Multiple Sclerosis (MS): MS is an autoimmune disorder characterized by inflammation and neuronal damage. CBD may help reduce inflammation and alleviate symptoms of MS. Additionally, CBD, often in combination with THC, has shown potential in reducing muscle spasticity in MS patients.

5. Amyotrophic Lateral Sclerosis (ALS): Preliminary research indicates that cannabinoids, including CBD, might slow the onset of ALS and prolong survival.

Chemotherapy-induced symptoms

CBD may help manage chemotherapy induced symptoms is several ways:

1. Nausea and Vomiting: One of the most common and distressing side effects of chemotherapy is nausea and vomiting. Some studies have suggested that CBD, often in combination with THC (another cannabinoid), can be effective in reducing chemotherapy-induced nausea and vomiting (CINV).

2. Neuropathic Pain: Chemotherapy can lead to neuropathic pain, which is challenging to manage with conventional medications. There's evidence to suggest that CBD might help alleviate neuropathic pain.

3. Appetite Stimulation: Loss of appetite is common in chemotherapy patients, which can lead to unintended weight loss and malnutrition. While THC is more commonly associated with appetite stimulation, CBD may also play a role in some patients.

4. Anxiety and Depression: A cancer diagnosis, coupled with the challenges of chemotherapy, can lead to anxiety and depression. Some research indicates that CBD has anxiolytic (anxiety-reducing) and antidepressant properties.

5. Bone Marrow Recovery: Preliminary animal studies suggest that CBD might accelerate bone marrow recovery after it's been damaged by chemotherapy, although more research is needed in this area.

Sleep

Some preliminary research suggests that CBD may help with falling asleep and staying asleep. CBD has also been shown to increase the amount of total sleep time in certain individuals. One of the reasons CBD may help with sleep is its potential anxiolytic (anxiety-reducing) effects. Anxiety can be a significant cause of sleep disturbances, and by reducing anxiety, CBD might indirectly promote better sleep. Patients with Parkinson's disease often suffer from REM sleep behaviour disorder, a condition where individuals act out their dreams. There's evidence suggesting that CBD may help reduce the occurrence of this disorder

Diabetes

CBD has demonstrated anti-inflammatory properties that could potentially benefit individuals with diabetes. Chronic inflammation plays a key role in the development of insulin resistance, which is a hallmark of type 2 diabetes. Diabetic neuropathy, a common complication of diabetes, causes pain and loss of sensation in extremities. CBD's neuroprotective and anti-inflammatory effects may help in alleviating neuropathic pain. A study on mice found that CBD could reduce the incidence of diabetes. It was observed that CBD reduced the production of pro-inflammatory cytokines, potentially protecting the insulin-producing cells of the pancreas. Preclinical studies also suggest that CBD might improve insulin resistance, although human trials are still needed to establish this potential benefit.

Weight Management

The potential role of CBD in weight management is a burgeoning area of interest. Preliminary studies suggest several ways through which CBD could influence weight:

• Appetite Regulation: While THC, another compound in cannabis, is known to increase appetite, CBD might have the opposite effect. Some animal studies have shown that CBD could reduce appetite by interacting with CB1 receptors.

• Reducing Fat Accumulation: CBD might promote the conversion of white fat cells, which store energy, into brown fat cells that burn energy. This process could aid in reducing fat accumulation and increasing energy expenditure.

• Mitigating Metabolic Disorders: There is evidence that CBD could benefit metabolic disorders, such as high cholesterol and diabetes, which are risk factors for weight gain.

It's crucial to note that human studies on CBD and weight management are still in early stages. While the initial findings are intriguing, more research is required before making concrete recommendations.

Full spectrum CBD vs. distillates and isolates

Full spectrum CBD contains all the compounds naturally present in the cannabis plant, including other cannabinoids (like THC, though in very low amounts in hemp-derived products), terpenes, and essential oils. This form of CBD is believed to offer what's called the “entourage effect.” This hypothesis suggests that the various components of the cannabis plant work synergistically to amplify the therapeutic properties of each individual cannabinoid. This means patients might benefit more from a full spectrum product than an isolate. It is important to note that full-spectrum CBD can contain trace amounts of THC so there is a minor risk of psychoactive effects or testing positive on a drug test.

CBD isolates contain only the CBD molecule, isolated from all other compounds. This pure form of CBD is ideal for those who are wary of THC or other cannabinoids, whether due to personal reasons, drug testing, or potential drug interactions. It's also more consistent in its CBD content, which can be helpful for precise dosing. Without the additional cannabinoids and terpenes, isolates don't benefit from the entourage effect. Thus, in conditions where this synergistic response is beneficial, isolates might be less effective than full spectrum or distillate products.

CBD distillates are refined cannabis extracts that contain a wider profile of cannabinoids and terpenes than isolates, but some compounds may have been removed. It can be though of as a middle ground between full spectrum and isolates. Distillates can provide a broad spectrum of cannabinoids and terpenes, offering some benefits of the entourage effect but without the potential risks associated with THC. However, the refining process might exclude beneficial compounds present in full spectrum formulations.

Potential side effects of CBD

While CBD is increasingly prescribed in Australia for potential therapeutic effects, users should be aware of potential side effects:

1. Drowsiness or Fatigue: Some individuals may experience drowsiness, suggesting caution when driving or operating machinery until its effects are known.

2. Diarrhea: High doses might lead to digestive disturbances in some people.

3. Appetite Changes: CBD can influence appetite, leading to increases or decreases.

4. Weight Changes: Possibly related to shifts in appetite or metabolic factors.

5. Dry Mouth: A side effect encountered with many cannabis products.

6. Low Blood Pressure: Higher doses can lead to a brief drop in blood pressure, potentially causing dizziness.

7. Lightheadedness: Might be due to the drop in blood pressure or other factors.

8. Liver Changes: Some research points to CBD affecting liver enzyme levels, indicating potential liver inflammation or damage.

9. Mood Changes: Though rare, mood swings or irritability might occur.

10. Interaction with Other Medications: CBD can interact with certain drugs, altering their effects.

Before using CBD in Australia, consult with a healthcare professional, especially if pregnant, nursing, or taking medications. Although CBD products can be legally purchased in Australia with a prescription, the Therapeutic Goods Administration (TGA) has certain guidelines around its use. Ensure that any product you obtain aligns with TGA guidelines to ensure safety and quality.

References

1. Babson, K. A., Sottile, J., & Morabito, D. (2017). Cannabis, cannabinoids, and sleep: a review of the literature. Current Psychiatry Reports, 19(4), 23.

2. Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836.

3. Chagas, M. H. N., Crippa, J. A. S., Zuardi, A. W., Hallak, J. E. C., Machado-de-Sousa, J. P., Hirotsu, C., ... & Andersen, M. L. (2013). Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, 27(3), 312-316.

4. Chagas, M. H. N., Eckeli, A. L., Zuardi, A. W., Pena-Pereira, M. A., Sobreira-Neto, M. A., Sobreira, E. T., ... & Tumas, V. (2014). Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. Journal of Clinical Pharmacy and Therapeutics, 39(5), 564-566.

5. Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., ... & Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 376(21), 2011-2020.

6. Ewing, L. E., Skinner, C. M., Quick, C. M., et al. (2019). Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model. Molecules, 24(9), 1694.

7. Esposito, G., Scuderi, C., Savani, C., Steardo Jr, L., De Filippis, D., Cottone, P., ... & Steardo, L. (2007). Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression. British Journal of Pharmacology, 151(8), 1272-1279.

8. Farrimond, J. A., Whalley, B. J., & Williams, C. M. (2012). Cannabinol and cannabidiol exert opposing effects on rat feeding patterns. Psychopharmacology, 223(1), 117-129.

9. Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, SL, Stinchcomb AL, Westlund KN. (2016). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.

10. Iffland, K., & Grotenhermen, F. (2017). An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research, 2(1), 139-154.

11. Jiang, R., Yamaori, S., Takeda, S., Yamamoto, I., & Watanabe, K. (2013). Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sciences, 93(6-7), 230-235.

12. Jadoon, K. A., Tan, G. D., & O'Sullivan, S. E. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI insight, 2(12), e93760.

13. Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., ... & Tan, G. D. (2016). Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study. Diabetes Care, 39(10), 1777-1786.

14. Khuja, I., Yekhtin, Z., Or, R., & Almogi-Hazan, O. (2019). Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation. International Journal of Molecular Sciences, 20(3), 668.

15. Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, A., ... & Díaz, Á. (2016). Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology, 103, 16-26.

16. Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Crippa, A. S. (2011). Safety and side effects of cannabidiol, a Cannabis sativa constituent. Current Drug Safety, 6(4), 237-249.

17. McAllister, S. D., Murase, R., Christian, R. T., Lau, D., Zielinski, A. J., Allison, J., ... & Desprez, P. Y. (2011). Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Research and Treatment, 129(1), 37-47.

18. McAllister, S. D., Soroceanu, L., & Desprez, P. Y. (2015). The antitumor activity of plant-derived non-psychoactive cannabinoids. Journal of Neuroimmune Pharmacology, 10(2), 255-267.

19. Murphy, M., Mills, S., Winstone, J., Leishman, E., Wager-Miller, J., Bradshaw, H., & Mackie, K. (2020). Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment. Cannabis and Cannabinoid Research, 5(4), 271-282.

20. Nicholson, A. N., Turner, C., Stone, B. M., & Robson, P. J. (2004). Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology, 24(3), 305-313. ↩

21. O'Sullivan, S. E., Sun, Y., Bennett, A. J., Randall, M. D., & Kendall, D. A. (2009). Time‐dependent vascular actions of cannabidiol in the rat aorta. European Journal of Pharmacology, 612(1-3), 61-68.

22. Pazos, M. R., Cinquina, V., Gómez, A., Layunta, R., Santos, M., Fernández-Ruiz, J., & Martínez-Orgado, J. (2012). Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology, 63(5), 776-783.

23. Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005). Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochemical Research, 30(8), 1037-1043. ↩

24. Shannon, S., & Opila-Lehman, J. (2016). Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. The Permanente Journal, 20(4), 108-111.

25. Stanley, C. P., Hind, W. H., O'Sullivan, S. E. (2013). Is the cardiovascular system a therapeutic target for cannabidiol? British Journal of Clinical Pharmacology, 75(2), 313-322.

26. Taylor, L., Gidal, B., Blakey, G., Tayo, B., & Morrison, G. (2018). A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs, 32(11), 1053-1067.

27. Whalley, B. J., Stott, C., & Gray, R. A. (2020). Progress in the chemistry of organic natural products: The pharmacology of cannabidiol and its synthetic derivatives. Progress in the Chemistry of Organic Natural Products, 111, 1-97.
    

Disclaimer

Medical Cannabis, like all other medications comes with the potential for risk and adverse side-effect including, but not limited to, sedation, vomiting, nausea, cotton mouth, appetite changes, paranoid delusions, vertigo, psychosis, euphoria, depression, confusion and other unknown side-effects. Cannabis interactions with other medications are currently unknown and the risk of addiction or dependence over time has been reported but not been well studied. The information provided on this website does not, and is not intended to, constitute legal or medical advice; instead, all information, content, and materials available on this site are for general informational purposes only. Information on this website may not constitute the most up-to-date legal, medical or other information.